glp-1 boost Understanding GLP-1: What You Need to Know BOOST Announces GLP-1 Inspired Protein
Description
Wegovy (semaglutide) Approved - An injectable GLP-1 receptor agonist approved for chronic weight management
Dear Editor, The global prevalence of type 2 diabetes and obesity, affecting over 507 million 1 and 890 million 2 individuals, respectively, underscores the urgent need for more effective treatments
Phase 2 : Overweight individuals with a BMI greater than 30, individuals with uncontrolled hypertension, kidney disease, or heart failure
Its antidiabetic action works by stimulating the GLP-1 receptor, increasing insulin production to convert the body's sugar levels to energy
When that protein is blocked, excess glucose is excreted in the urine
R.LewisB.OslicaR.FrancisW.et al (2021)
